Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT: Oral Tranexamic Acid for PPH
NCT06025916Phase 4Recruiting
- Sponsor
- Karolinska Institutet
- Start
- Sep 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Rate of Postpartum Hemorrhage (>=500ml) at 24 hours. Started Sep 2023; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT06025916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06025916.